Alembic pharmaceuticals announces USFDA Final Approval for brimonidine tartrate ophthalmic solution 0.15%.
Podcast: Talking about the anterior segment pipeline for 2023
Recipe for disaster? Starting out in ophthalmology during the pandemic
The importance of ocular health prior to cataract and refractive surgery
FDA approves twice-daily dosing option for presbyopia eye drop treatment
American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services
2 Clarke Drive Cranbury, NJ 08512